The availability of the 750mcg parathyroid hormone solution in Australia has seen cautious uptake. Currently, this increased dose medication is primarily designated for patients with significant osteoporosis read more who have failed with other treatments . Procurement can be complex due to physician approval stipulations and restricted supplier di